We are live on ! Find out more
OAM

Oppenheimer Asset Management Portfolio holdings

AUM $9.63B
1-Year Est. Return 30.32%
This Fund
S&P 500
This Quarter Est. Return
+4.61%
1 Year Est. Return
+30.32%
3 Year Est. Return
+85%
5 Year Est. Return
+99.62%
10 Year Est. Return
+601.29%
AUM
$3.85B
AUM Growth
+$230M
Cap. Flow
+$85.4M
Cap. Flow %
2.22%
Top 10 Hldgs %
13.56%
Holding
1,766
New
85
Increased
690
Reduced
800
Closed
84

Top Sells

Rank Stock Value
1
DD
Du Pont De Nemours E I
DD
+$14.2M
2
BHI
Baker Hughes
BHI
+$12.3M
3
MCHP icon
Microchip Technology
MCHP
+$7.9M
4
MAT icon
Mattel
MAT
+$7.07M
5
BA icon
Boeing
BA
+$6.9M

Sector Composition

Rank Sector Weight
1 Financials 15.43%
2 Technology 14.53%
3 Healthcare 14.49%
4 Industrials 12.48%
5 Consumer Discretionary 8.93%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CXT icon
951
Crane NXT
CXT
$3.13B
$280K 0.01%
+10,062
New +$270K
DHC
952
Diversified Healthcare Trust
DHC
$2.11B
$280K 0.01%
14,327
-2,457
-15% -$47.9K
RP
953
DELISTED
RealPage, Inc.
RP
$280K 0.01%
7,013
-59
-0.8% -$2.35K
PCRX icon
954
Pacira BioSciences
PCRX
$1.02B
$277K 0.01%
7,375
+4,976
+207% +$200K
RRC icon
955
Range Resources
RRC
$9.01B
$277K 0.01%
14,120
-656
-4% -$12.7K
AVNT icon
956
Avient
AVNT
$3.91B
$276K 0.01%
6,887
-17
-0.2% -$634
ACIW icon
957
ACI Worldwide
ACIW
$5.61B
$275K 0.01%
12,061
-224
-2% -$5.07K
VOX icon
958
Vanguard Communication Services ETF
VOX
$5.73B
$274K 0.01%
+2,970
New +$274K
TMX
959
DELISTED
Terminix Global Holdings, Inc.
TMX
$273K 0.01%
8,706
-280
-3% -$8.26K
GMED icon
960
Globus Medical
GMED
$11B
$272K 0.01%
9,140
+716
+8% +$21.9K
KEX icon
961
Kirby Corp
KEX
$7.02B
$272K 0.01%
4,115
-102
-2% -$6.46K
GT icon
962
Goodyear
GT
$1.94B
$271K 0.01%
8,129
+150
+2% +$4.87K
MORN icon
963
Morningstar
MORN
$7.37B
$271K 0.01%
3,184
-35
-1% -$2.85K
QLYS icon
964
Qualys
QLYS
$6.29B
$271K 0.01%
5,227
-35
-0.7% -$1.61K
RSPP
965
DELISTED
RSP Permian, Inc.
RSPP
$271K 0.01%
7,836
-158
-2% -$5.08K
MON
966
DELISTED
Monsanto Co
MON
$271K 0.01%
2,262
+53
+2% +$6.24K
AMN icon
967
AMN Healthcare
AMN
$1.19B
$270K 0.01%
5,915
-48
-0.8% -$1.83K
NUE icon
968
Nucor
NUE
$61.9B
$270K 0.01%
4,823
+241
+5% +$13.6K
ANDV
969
DELISTED
Andeavor
ANDV
$269K 0.01%
2,611
-178
-6% -$17.5K
OZK icon
970
Bank OZK
OZK
$5.63B
$267K 0.01%
5,558
-138
-2% -$6.15K
EGBN icon
971
Eagle Bancorp
EGBN
$849M
$266K 0.01%
3,966
+1,092
+38% +$68.5K
DXCM icon
972
DexCom
DXCM
$31.3B
$265K 0.01%
21,636
-76,740
-78% -$1.36M
SBGI icon
973
Sinclair Inc
SBGI
$1.07B
$264K 0.01%
8,225
-53
-0.6% -$1.66K
BSCO
974
DELISTED
Invesco BulletShares 2024 Corporate Bond ETF
BSCO
$264K 0.01%
12,582
-154
-1% -$3.23K
BFAM icon
975
Bright Horizons
BFAM
$3.89B
$261K 0.01%
3,033
-427
-12% -$34K

Similar funds

Oppenheimer Asset Management's Q3 2017 Portfolio in Review

As of Q3 2017, Oppenheimer Asset Management held 1,766 positions worth $3.85B, up 6.4% from $3.62B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Oppenheimer Asset Management's Q3 2017 filing shows 85 new, 690 increased, 800 reduced and 84 closed positions. Its largest new stake was Baker Hughes: 313,683 shares worth $11.5M. The largest sale was Du Pont De Nemours E I, an estimated $14.2M.

By sector, the portfolio is most concentrated in Financials at 15% of assets, up from 15% a quarter earlier, followed by Technology and Healthcare.

  • Oppenheimer Asset Management's largest Q3 2017 buy was Baker Hughes: 313,683 shares worth $11.5M.
  • Oppenheimer Asset Management added most to Advance Auto Parts in Q3 2017, an estimated $36.4M increase.
  • Oppenheimer Asset Management's biggest Q3 2017 reduction was Microchip Technology, cutting an estimated $7.9M.
  • Oppenheimer Asset Management fully exited Du Pont De Nemours E I in Q3 2017, selling an estimated $14.2M.
  • Oppenheimer Asset Management's ten largest holdings make up 14% of its $3.85B portfolio in Q3 2017.
  • Oppenheimer Asset Management opened 85 new positions and closed 84 in Q3 2017.
  • Oppenheimer Asset Management's portfolio value rose 6.4% quarter-over-quarter to $3.85B.

Based on Oppenheimer Asset Management's 13F filing for Q3 2017, filed 14 Nov 2017.